(2R,3R)-1-[2-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-1-[3-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-2,3-dihydroxy-N,N-dimethyl-4-oxo-4-[4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-4-[4-hydroxy-4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]-N,N-dimethyl-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-1-(4-naphthalen-2-ylpiperidin-1-yl)-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-[5-(2-phenylethynyl)indol-1-yl]-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-pyrrolidin-1-yl-4-[4-[4-(trifluoromethyl)phenyl]piperidin-1-yl]butane-1,4-dione

C177H181Cl2F3N14O29 — CID 160713012

About (2R,3R)-1-[2-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-1-[3-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-2,3-dihydroxy-N,N-dimethyl-4-oxo-4-[4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-4-[4-hydroxy-4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]-N,N-dimethyl-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-1-(4-naphthalen-2-ylpiperidin-1-yl)-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-[5-(2-phenylethynyl)indol-1-yl]-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-pyrrolidin-1-yl-4-[4-[4-(trifluoromethyl)phenyl]piperidin-1-yl]butane-1,4-dione

(2R,3R)-1-[2-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-1-[3-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-2,3-dihydroxy-N,N-dimethyl-4-oxo-4-[4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-4-[4-hydroxy-4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]-N,N-dimethyl-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-1-(4-naphthalen-2-ylpiperidin-1-yl)-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-[5-(2-phenylethynyl)indol-1-yl]-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-pyrrolidin-1-yl-4-[4-[4-(trifluoromethyl)phenyl]piperidin-1-yl]butane-1,4-dione (PubChem CID 160713012) has the molecular formula C177H181Cl2F3N14O29 and a molecular weight of 3096.36 g/mol. Its IUPAC name is (2R,3R)-1-[2-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-1-[3-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-2,3-dihydroxy-N,N-dimethyl-4-oxo-4-[4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-4-[4-hydroxy-4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]-N,N-dimethyl-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-1-(4-naphthalen-2-ylpiperidin-1-yl)-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-[5-(2-phenylethynyl)indol-1-yl]-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-pyrrolidin-1-yl-4-[4-[4-(trifluoromethyl)phenyl]piperidin-1-yl]butane-1,4-dione.

Molecular Properties

• Compound Name: (2R,3R)-1-[2-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-1-[3-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-2,3-dihydroxy-N,N-dimethyl-4-oxo-4-[4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-4-[4-hydroxy-4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]-N,N-dimethyl-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-1-(4-naphthalen-2-ylpiperidin-1-yl)-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-[5-(2-phenylethynyl)indol-1-yl]-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-pyrrolidin-1-yl-4-[4-[4-(trifluoromethyl)phenyl]piperidin-1-yl]butane-1,4-dione
• PubChem CID: 160713012
• Molecular Formula: C177H181Cl2F3N14O29
• Molecular Weight: 3096.36 g/mol
• Exact Mass: 3093.24
• IUPAC Name: (2R,3R)-1-[2-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-1-[3-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-2,3-dihydroxy-N,N-dimethyl-4-oxo-4-[4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-4-[4-hydroxy-4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]-N,N-dimethyl-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-1-(4-naphthalen-2-ylpiperidin-1-yl)-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-[5-(2-phenylethynyl)indol-1-yl]-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-pyrrolidin-1-yl-4-[4-[4-(trifluoromethyl)phenyl]piperidin-1-yl]butane-1,4-dione
• SMILES: CN(C)C(=O)[C@H](O)[C@@H](O)C(=O)N1CCC(O)(c2ccc(C#Cc3ccccc3)cc2)CC1.CN(C)C(=O)[C@H](O)[C@@H](O)C(=O)N1CCC(c2ccc(C#Cc3ccccc3)cc2)CC1.O=C([C@H](O)[C@@H](O)C(=O)N1CCC(c2ccc(C(F)(F)F)cc2)CC1)N1CCCC1.O=C([C@H](O)[C@@H](O)C(=O)N1CCC(c2ccc3ccccc3c2)CC1)N1CCCC1.O=C([C@H](O)[C@@H](O)C(=O)n1ccc2cc(C#Cc3ccccc3)ccc21)N1CCC(c2cccc(Cl)c2)C1.O=C([C@H](O)[C@@H](O)C(=O)n1ccc2cc(C#Cc3ccccc3)ccc21)N1CCCC1.O=C([C@H](O)[C@@H](O)C(=O)n1ccc2cc(C#Cc3ccccc3)ccc21)N1CCCC1c1cccc(Cl)c1
• InChI: InChI=1S/2C30H25ClN2O4.C25H28N2O5.C25H28N2O4.C24H22N2O4.C23H28N2O4.C20H25F3N2O4/c31-24-9-4-8-22(19-24)25-10-5-16-32(25)29(36)27(34)28(35)30(37)33-17-15-23-18-21(13-14-26(23)33)12-11-20-6-2-1-3-7-20;31-25-8-4-7-22(18-25)24-13-15-32(19-24)29(36)27(34)28(35)30(37)33-16-14-23-17-21(11-12-26(23)33)10-9-20-5-2-1-3-6-20;1-26(2)23(30)21(28)22(29)24(31)27-16-14-25(32,15-17-27)20-12-10-19(11-13-20)9-8-18-6-4-3-5-7-18;1-26(2)24(30)22(28)23(29)25(31)27-16-14-21(15-17-27)20-12-10-19(11-13-20)9-8-18-6-4-3-5-7-18;27-21(23(29)25-13-4-5-14-25)22(28)24(30)26-15-12-19-16-18(10-11-20(19)26)9-8-17-6-2-1-3-7-17;26-20(22(28)24-11-3-4-12-24)21(27)23(29)25-13-9-17(10-14-25)19-8-7-16-5-1-2-6-18(16)15-19;21-20(22,23)15-5-3-13(4-6-15)14-7-11-25(12-8-14)19(29)17(27)16(26)18(28)24-9-1-2-10-24/h1-4,6-9,13-15,17-19,25,27-28,34-35H,5,10,16H2;1-8,11-12,14,16-18,24,27-28,34-35H,13,15,19H2;3-7,10-13,21-22,28-29,32H,14-17H2,1-2H3;3-7,10-13,21-23,28-29H,14-17H2,1-2H3;1-3,6-7,10-12,15-16,21-22,27-28H,4-5,13-14H2;1-2,5-8,15,17,20-21,26-27H,3-4,9-14H2;3-6,14,16-17,26-27H,1-2,7-12H2/t25?,27-,28-;24?,27-,28-;21-,22-;22-,23-;21-,22-;20-,21-;16-,17-/m1111111/s1
• InChIKey: RSCLCRMARZEJFG-QGJVHUFTSA-N
• XLogP: 16.47
• TPSA: 592.86 Ų
• H-Bond Donors: 15
• H-Bond Acceptors: 32
• Rotatable Bonds: 27
• Heavy Atoms: 225
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3096.36
LogP ≤ 5	16.47
H-Bond Donors ≤ 5	15
H-Bond Acceptors ≤ 10	32

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of (2R,3R)-1-[2-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-1-[3-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-2,3-dihydroxy-N,N-dimethyl-4-oxo-4-[4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-4-[4-hydroxy-4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]-N,N-dimethyl-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-1-(4-naphthalen-2-ylpiperidin-1-yl)-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-[5-(2-phenylethynyl)indol-1-yl]-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-pyrrolidin-1-yl-4-[4-[4-(trifluoromethyl)phenyl]piperidin-1-yl]butane-1,4-dione?

The IUPAC name of (2R,3R)-1-[2-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-1-[3-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-2,3-dihydroxy-N,N-dimethyl-4-oxo-4-[4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-4-[4-hydroxy-4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]-N,N-dimethyl-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-1-(4-naphthalen-2-ylpiperidin-1-yl)-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-[5-(2-phenylethynyl)indol-1-yl]-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-pyrrolidin-1-yl-4-[4-[4-(trifluoromethyl)phenyl]piperidin-1-yl]butane-1,4-dione (CID 160713012) is (2R,3R)-1-[2-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-1-[3-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-2,3-dihydroxy-N,N-dimethyl-4-oxo-4-[4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-4-[4-hydroxy-4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]-N,N-dimethyl-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-1-(4-naphthalen-2-ylpiperidin-1-yl)-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-[5-(2-phenylethynyl)indol-1-yl]-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-pyrrolidin-1-yl-4-[4-[4-(trifluoromethyl)phenyl]piperidin-1-yl]butane-1,4-dione.

What is the SMILES notation for (2R,3R)-1-[2-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-1-[3-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-2,3-dihydroxy-N,N-dimethyl-4-oxo-4-[4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-4-[4-hydroxy-4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]-N,N-dimethyl-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-1-(4-naphthalen-2-ylpiperidin-1-yl)-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-[5-(2-phenylethynyl)indol-1-yl]-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-pyrrolidin-1-yl-4-[4-[4-(trifluoromethyl)phenyl]piperidin-1-yl]butane-1,4-dione?

The canonical SMILES for (2R,3R)-1-[2-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-1-[3-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-2,3-dihydroxy-N,N-dimethyl-4-oxo-4-[4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-4-[4-hydroxy-4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]-N,N-dimethyl-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-1-(4-naphthalen-2-ylpiperidin-1-yl)-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-[5-(2-phenylethynyl)indol-1-yl]-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-pyrrolidin-1-yl-4-[4-[4-(trifluoromethyl)phenyl]piperidin-1-yl]butane-1,4-dione is CN(C)C(=O)[C@H](O)[C@@H](O)C(=O)N1CCC(O)(c2ccc(C#Cc3ccccc3)cc2)CC1.CN(C)C(=O)[C@H](O)[C@@H](O)C(=O)N1CCC(c2ccc(C#Cc3ccccc3)cc2)CC1.O=C([C@H](O)[C@@H](O)C(=O)N1CCC(c2ccc(C(F)(F)F)cc2)CC1)N1CCCC1.O=C([C@H](O)[C@@H](O)C(=O)N1CCC(c2ccc3ccccc3c2)CC1)N1CCCC1.O=C([C@H](O)[C@@H](O)C(=O)n1ccc2cc(C#Cc3ccccc3)ccc21)N1CCC(c2cccc(Cl)c2)C1.O=C([C@H](O)[C@@H](O)C(=O)n1ccc2cc(C#Cc3ccccc3)ccc21)N1CCCC1.O=C([C@H](O)[C@@H](O)C(=O)n1ccc2cc(C#Cc3ccccc3)ccc21)N1CCCC1c1cccc(Cl)c1.

What is the InChIKey of (2R,3R)-1-[2-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-1-[3-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-2,3-dihydroxy-N,N-dimethyl-4-oxo-4-[4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-4-[4-hydroxy-4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]-N,N-dimethyl-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-1-(4-naphthalen-2-ylpiperidin-1-yl)-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-[5-(2-phenylethynyl)indol-1-yl]-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-pyrrolidin-1-yl-4-[4-[4-(trifluoromethyl)phenyl]piperidin-1-yl]butane-1,4-dione?

The InChIKey is RSCLCRMARZEJFG-QGJVHUFTSA-N. The full InChI is InChI=1S/2C30H25ClN2O4.C25H28N2O5.C25H28N2O4.C24H22N2O4.C23H28N2O4.C20H25F3N2O4/c31-24-9-4-8-22(19-24)25-10-5-16-32(25)29(36)27(34)28(35)30(37)33-17-15-23-18-21(13-14-26(23)33)12-11-20-6-2-1-3-7-20;31-25-8-4-7-22(18-25)24-13-15-32(19-24)29(36)27(34)28(35)30(37)33-16-14-23-17-21(11-12-26(23)33)10-9-20-5-2-1-3-6-20;1-26(2)23(30)21(28)22(29)24(31)27-16-14-25(32,15-17-27)20-12-10-19(11-13-20)9-8-18-6-4-3-5-7-18;1-26(2)24(30)22(28)23(29)25(31)27-16-14-21(15-17-27)20-12-10-19(11-13-20)9-8-18-6-4-3-5-7-18;27-21(23(29)25-13-4-5-14-25)22(28)24(30)26-15-12-19-16-18(10-11-20(19)26)9-8-17-6-2-1-3-7-17;26-20(22(28)24-11-3-4-12-24)21(27)23(29)25-13-9-17(10-14-25)19-8-7-16-5-1-2-6-18(16)15-19;21-20(22,23)15-5-3-13(4-6-15)14-7-11-25(12-8-14)19(29)17(27)16(26)18(28)24-9-1-2-10-24/h1-4,6-9,13-15,17-19,25,27-28,34-35H,5,10,16H2;1-8,11-12,14,16-18,24,27-28,34-35H,13,15,19H2;3-7,10-13,21-22,28-29,32H,14-17H2,1-2H3;3-7,10-13,21-23,28-29H,14-17H2,1-2H3;1-3,6-7,10-12,15-16,21-22,27-28H,4-5,13-14H2;1-2,5-8,15,17,20-21,26-27H,3-4,9-14H2;3-6,14,16-17,26-27H,1-2,7-12H2/t25?,27-,28-;24?,27-,28-;21-,22-;22-,23-;21-,22-;20-,21-;16-,17-/m1111111/s1.

What are the key properties of (2R,3R)-1-[2-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-1-[3-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-2,3-dihydroxy-N,N-dimethyl-4-oxo-4-[4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-4-[4-hydroxy-4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]-N,N-dimethyl-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-1-(4-naphthalen-2-ylpiperidin-1-yl)-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-[5-(2-phenylethynyl)indol-1-yl]-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-pyrrolidin-1-yl-4-[4-[4-(trifluoromethyl)phenyl]piperidin-1-yl]butane-1,4-dione?

(2R,3R)-1-[2-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-1-[3-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-2,3-dihydroxy-N,N-dimethyl-4-oxo-4-[4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-4-[4-hydroxy-4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]-N,N-dimethyl-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-1-(4-naphthalen-2-ylpiperidin-1-yl)-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-[5-(2-phenylethynyl)indol-1-yl]-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-pyrrolidin-1-yl-4-[4-[4-(trifluoromethyl)phenyl]piperidin-1-yl]butane-1,4-dione has a molecular weight of 3096.36 g/mol, XLogP of 16.47, 27 rotatable bonds, 15 hydrogen bond donors, and 32 hydrogen bond acceptors.

Where does this data come from?

All data for (2R,3R)-1-[2-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-1-[3-(3-chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-[5-(2-phenylethynyl)indol-1-yl]butane-1,4-dione;(2R,3R)-2,3-dihydroxy-N,N-dimethyl-4-oxo-4-[4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-4-[4-hydroxy-4-[4-(2-phenylethynyl)phenyl]piperidin-1-yl]-N,N-dimethyl-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-1-(4-naphthalen-2-ylpiperidin-1-yl)-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-[5-(2-phenylethynyl)indol-1-yl]-4-pyrrolidin-1-ylbutane-1,4-dione;(2R,3R)-2,3-dihydroxy-1-pyrrolidin-1-yl-4-[4-[4-(trifluoromethyl)phenyl]piperidin-1-yl]butane-1,4-dione is sourced from PubChem (CID 160713012), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).